BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36895021)

  • 1. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.
    Zhang W; Wu Y; Wen B; Zhang Y; Wang Y; Yin W; Sun S; Wei X; Sun H; Zhang Z; Li S; Guo Y
    Infect Dis Poverty; 2023 Mar; 12(1):15. PubMed ID: 36895021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different levels of non-pharmaceutical interventions on hand, foot and mouth disease in Guangzhou, China.
    Wu K; Ma X; Liu H; Zheng J; Zhou R; Yuan Z; Huang Z; Zhong Q; Huang Y; Zhang Z; Wu X
    BMC Public Health; 2022 Dec; 22(1):2398. PubMed ID: 36539790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study interrupted time-series analysis.
    Maglietta G; Puntoni M; Caminiti C; Pession A; Lanari M; Caramelli F; Marchetti F; De Fanti A; Iughetti L; Biasucci G; Suppiej A; Miceli A; Ghizzi C; Vergine G; Aricò M; Stella M; Esposito S;
    Front Public Health; 2024; 12():1393677. PubMed ID: 38699417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of national COVID-19 restrictions on incidence of notifiable communicable diseases in England: an interrupted time series analysis.
    Nash K; Lai J; Sandhu K; Chandan JS; Shantikumar S; Ogunlayi F; Coleman PC
    BMC Public Health; 2022 Dec; 22(1):2318. PubMed ID: 36510205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.
    Chang T; Cho SI; Yoo DS; Min KD
    Emerg Infect Dis; 2024 Jun; 30(6):1154-1163. PubMed ID: 38781924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.
    Geng MJ; Zhang HY; Yu LJ; Lv CL; Wang T; Che TL; Xu Q; Jiang BG; Chen JJ; Hay SI; Li ZJ; Gao GF; Wang LP; Yang Y; Fang LQ; Liu W
    Nat Commun; 2021 Nov; 12(1):6923. PubMed ID: 34836947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019.
    Du M; Wang R; Yuan J; Lv X; Yan W; Liu Q; Qin C; Xiang N; Zhu L; Liang W; Liu M; Liu J
    J Med Virol; 2023 Jan; 95(1):e28353. PubMed ID: 36443103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.
    Chen B; Wang M; Huang X; Xie M; Pan L; Liu H; Liu Z; Zhou P
    Front Public Health; 2021; 9():728768. PubMed ID: 34722440
    [No Abstract]   [Full Text] [Related]  

  • 10. Immediate and long-term changes in infectious diseases in China at the "First-level-response", "Normalized-control" and "Dynamic-COVID-zero" stages from 2020 to 2022: a multistage interrupted-time-series-analysis.
    Shi T; Zhang X; Meng L; Li D; Jin N; Zhao X; Zheng H; Wang T; Li R; Ren X
    BMC Public Health; 2023 Jul; 23(1):1381. PubMed ID: 37464368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.
    Liu W; Wang R; Li Y; Zhao S; Chen Y; Zhao Y
    BMC Public Health; 2023 Jun; 23(1):1089. PubMed ID: 37280569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of non-pharmaceutical interventions on COVID-19 cases in South Australia and Victoria.
    Milazzo A; Giles L; Parent N; McCarthy S; Laurence C
    Aust N Z J Public Health; 2022 Aug; 46(4):482-487. PubMed ID: 35557482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.
    Chen L; Wang L; Xing Y; Xie J; Su B; Geng M; Ren X; Zhang Y; Liu J; Ma T; Chen M; Miller JE; Dong Y; Song Y; Ma J; Sawyer S
    JMIR Public Health Surveill; 2024 May; 10():e47626. PubMed ID: 38748469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the effectiveness of non-pharmaceutical interventions on influenza during the Coronavirus disease 2019 pandemic by time-series forecasting.
    Kim HK; Min KD; Cho SI
    BMC Infect Dis; 2023 Oct; 23(1):717. PubMed ID: 37875817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal impact of non-pharmaceutical interventions against COVID-19 on the incidence of infectious diarrhea in Xi'an, China.
    Zhang H; Shen L; Sun M; Zhao C; Li Q; Yang Z; Liu J; Liu K; Xiao B
    Front Public Health; 2022; 10():1011592. PubMed ID: 36518571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of non-pharmaceutical interventions on total disease burden in parsimonious epidemiological models.
    Fung T; Goh J; Chisholm RA
    J Theor Biol; 2024 Jun; 587():111817. PubMed ID: 38599566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of stringent non-pharmaceutical interventions applied during the second and third COVID-19 epidemic waves in Portugal, 9 November 2020 to 10 February 2021: an ecological study.
    Torres AR; Rodrigues AP; Sousa-Uva M; Kislaya I; Silva S; Antunes L; Dias C; Nunes B
    Euro Surveill; 2022 Jun; 27(23):. PubMed ID: 35686568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
    Rybak A; Levy C; Angoulvant F; Auvrignon A; Gembara P; Danis K; Vaux S; Levy-Bruhl D; van der Werf S; Béchet S; Bonacorsi S; Assad Z; Lazzati A; Michel M; Kaguelidou F; Faye A; Cohen R; Varon E; Ouldali N
    JAMA Netw Open; 2022 Jun; 5(6):e2218959. PubMed ID: 35763298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Non-pharmaceutical Interventions on COVID-19 in Rwanda: An Observational Study.
    Rwagasore E; Nsekuye O; Rutagengwa A; El-Khatib Z
    J Epidemiol Glob Health; 2023 Jun; 13(2):239-247. PubMed ID: 36892779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks.
    Kohanovski I; Obolski U; Ram Y
    Int J Infect Dis; 2022 Apr; 117():361-368. PubMed ID: 34986406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.